Doctor Arnaud Bisson
CHU de Tours, Tours (France)
Member of:
/f/125658/4252x1496/43d16b540f/ehra-acronym-name-rgb.png)
Phenotypes and outcomes in patients with atrial fibrillation: a global unsupervised cluster analysis from Phase II/III of the GLORIA-AF registry
Event: EHRA 2024
Topic: Artificial Intelligence (Machine Learning, Deep Learning)
Session: Poster session on devices, others
Impact of environment and ethnicity on prognosis in AF patients: does the 'where' matter more than the 'who'?
Event: EHRA 2024
Topic: Hospital Information Systems, Electronic Medical Records, Clinical Decision Support
Session: Poster session on devices, others
Mortality prediction in patient with atrial fibrillation and 0 or 1 nongender-related CHA2DS2-Vasc risk factor using machine learning: a French nationwide study
Event: ESC Congress 2023
Topic: Public Health
Session: Digital advances in optimising cardiovascular health
Prediction of early death after atrial fibrillation diagnosis: a french nationwide study
Event: EHRA 2023
Topic: Artificial Intelligence (Machine Learning, Deep Learning)
Session: e-Cardiology/Digital Health
All-cause mortality and cardiac resynchronization therapy with or without defibrillation in primary prevention
Event: ESC Congress 2020
Topic: Cardioversion and Defibrillation
Session: Blockbusters from the Young in Arrhythmias
Futility risk model development and validation among patients with aortic stenosis treated with transcatheter aortic valve replacement
Event: ESC Congress 2019
Topic: Aortic Valve Stenosis
Session: Transcatheter aortic interventions
Are the results of the CASTLE-AF trial reproducible in the real life? Clinical outcomes after catheter ablation for atrial fibrillation with heart failure in a nationwide cohort study
Event: EHRA 2019
Topic: Rhythm Control, Catheter Ablation
Session: Atrial Fibrillation - Treatment
Clinical outcomes after catheter ablation for atrial fibrillation in elderly patients: a French nationwide cohort study
Event: EHRA 2019
Topic: Rhythm Control, Catheter Ablation
Session: Atrial Fibrillation - Treatment
Is atrio-ventricular node ablation a neglected option after failure of atrial fibrillation ablation? a French nationwide cohort study
Event: EHRA 2019
Topic: Rate Control
Session: Atrial Fibrillation - Treatment
Patients with atrial fibrillation and a possibly temporary cause: a different prognosis when atrial fibrillation is paroxysmal or persistent?
Event: EHRA 2019
Topic: Defining Types of Atrial Fibrillation
Session: Atrial Fibrillation - Pathophysiology and Mechanisms
